Table 1.
Demographic and clinical characteristics of COVID-19 patients.
| Variable | Total (n = 6 89) | Died (n = 1 03) | Discharged alive (n = 5 86) | p-value |
|---|---|---|---|---|
| Age categories, years (%) | ||||
| 18–39 | 199 (100) | 6 (3.0) | 193 (97.0) | <0.001∗ |
| 40–49 | 136 (100) | 15 (11.0) | 121 (89.0) | |
| 50–59 | 157 (100) | 30 (19.1) | 127 (80.9) | |
| 60–69 | 126 (100) | 26 (20.6) | 100 (79.4) | |
| ≥70 | 71 (100) | 26 (36.6) | 45 (63.4) | |
| Sex (%)∗ | ||||
| Male | 358 (100) | 62 (17.3) | 296 (82.7) | 0.070 |
| Female | 331 (100) | 41 (12.4) | 290 (87.6) | |
| Comorbidities (%)+ | ||||
| Any | 396 (100) | 77 (19.4) | 319 (80.6) | <0.001∗ |
| Coronary heart disease | 71 (100) | 17 (23.9) | 54 (76.1) | <0.001∗ |
| Hypertension | 187 (100) | 42 (22.5) | 145 (77.5) | <0.001∗ |
| Diabetes mellitus | 121 (100) | 33 (27.3) | 88 (72.7) | <0.001∗ |
| Chronic kidney disease | 42 (100) | 12 (28.6) | 30 (71.4) | <0.001∗ |
| No comorbidities | 293 (100) | 26 (8.9) | 267 (91.1) | |
| Signs and symptoms on presentation (%) | ||||
| Cough | ||||
| Yes | 484 (100) | 85 (17.6) | 399 (82.4) | 0.003∗ |
| No | 204 (100) | 18 (8.8) | 186 (91.2) | |
| Fever | ||||
| Yes | 469 (100) | 81 (17.3) | 388 (82.7) | 0.013∗ |
| No | 219 (100) | 22 (10.0) | 197 (90.0) | |
| Dyspnea | ||||
| Yes | 366 (100) | 91 (24.9) | 275 (75.1) | <0.001∗ |
| No | 322 (100) | 12 (3.7) | 310 (96.3) | |
| Headache | ||||
| Yes | 86 (100) | 10 (11.6) | 76 (88.4) | 0.353 |
| No | 602 (100) | 93 (15.4) | 509 (84.6) | |
| Nausea or vomiting | ||||
| Yes | 78 (100) | 9 (11.5) | 69 (88.5) | 0.367 |
| No | 610 (100) | 94 (15.4) | 516 (84.6) | |
| Diarrhea | ||||
| Yes | 34 (100) | 6 (17.6) | 28 (82.4) | 0.654 |
| No | 654 (100) | 97 (14.8) | 557 (85.2) | |
| Time from illness onset to hospital admission, (IQR), days∗ | 6 (3–8) | 5 (3–7) | 6 (4–9) | 0.009∗ |
| ≤7 | 392 (100) | 77 (19.6) | 315 (80.4) | 0.047∗ |
| 8–14 | 140 (100) | 16 (11.4) | 124 (88.6) | |
| >14 | 45 (100) | 5 (11.1) | 40 (88.9) | |
| Respiratory rate, median (IQR), breaths/min | 22 (20–26) | 28 (24–32) | 22 (20–24) | <0.001∗ |
| >24 | 216 (100) | 73 (33.8) | 143 (66.2) | <0.001∗ |
| ≤24 | 472 (100) | 30 (6.4) | 442 (93.6) | |
| Pulse, median (IQR), beats/min | 92 (84–104) | 102 (92–112) | 92 (84–100) | <0.001∗ |
| ≥100 | 190 (100) | 52 (27.4) | 138 (72.6) | <0.001∗ |
| <100 | 498 (100) | 51 (10.2) | 447 (89.8) | |
| Oxygen saturation, median (IQR), % | 96 (94–98) | 92 (80–96) | 97 (95–98) | <0.001∗ |
| <90 | 106 (100) | 46 (43.4) | 60 (56.6) | <0.001∗ |
| ≥90 | 575 (100) | 55 (9.6) | 520 (90.4) | |
| Temperature, median (range) | 36.8 (36.5–37.2) | 37.0 (36.5–37.8) | 36.8 (36.5–37.0) | 0.010∗ |
| ≥37.5 | 139 (100) | 35 (25.2) | 104 (74.8) | <0.001∗ |
| <37.5 | 550 (100) | 68 (12.4) | 482 (87.6) | |
| Disease severity (%) | ||||
| Mild/moderate | 538 (100) | 39 (7.2) | 499 (92.8) | <0.001∗ |
| Severe | 151 (100) | 64 (42.4) | 87 (57.6) |
COVID-19, coronavirus disease 2019; IQR, Interquartile Range; ∗, statistically significant (p-value <0.05); + comorbidity categories are not mutually exclusive.